Ipamorelin

Ipamorelin is a synthetic growth hormone–releasing peptide (GHRP) supplied as a high-purity lyophilized compound intended exclusively for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure molecular consistency, analytical reliability, and stability.

For laboratory research use only. 

Available concentrations:10 mg

Technical Classification

• Peptide Type: Synthetic growth hormone–releasing peptide (GHRP)

• Peptide Class: Ghrelin receptor (GHS-R1a) agonist analog

• Amino Acid Length: Pentapeptide

• Structural Type: Linear peptide

• Source: Synthetic (laboratory-produced)

• Physical Form: Lyophilized powder

• Purity: >99% (HPLC)

Research Context

Ipamorelin is utilized in preclinical and experimental research settings investigating:

• Growth hormone secretagogue receptor (GHS-R1a) signaling

• Pulsatile growth hormone release mechanisms

• Hypothalamic–pituitary axis regulation

• Peptide-receptor binding selectivity and signaling specificity

• Comparative analysis of GHRP family peptides

• Endocrine feedback loop modeling in experimental systems

Ipamorelin has been studied in in vitro and animal models for its role in selective GH-related signaling with minimal off-target endocrine activity compared to earlier GHRP analogs. Research applications focus on mechanistic pathway exploration and receptor-level analysis, not therapeutic use.

Handling & Storage

• Storage Conditions: 2–8 °C, protected from light

• Stability: Lyophilized format supports extended stability when stored under recommended conditions

• Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques